Optiver Holding’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$454 Sell
114
-336
-75% -$924 ﹤0.01% 2579
2026
Q1
$603 Sell
450
-368
-45% -$733 ﹤0.01% 2139
2025
Q4
$2K Hold
818
﹤0.01% 2018
2025
Q3
$5.49K Buy
+818
New +$5.34K ﹤0.01% 1668

Other funds holding TMCI

Optiver Holding's TMCI Position: Q2 2026 in Review

Optiver Holding reduced its Treace Medical Concepts (TMCI) stake by 75% in Q2 2026, selling an estimated $924 and leaving 114 shares worth $454. The position accounts for ﹤0.01% of the portfolio, ranked #2579.

Optiver Holding first reported a position in TMCI in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.49K in Q3 2025. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Optiver Holding held 114 shares of Treace Medical Concepts worth $454 as of Q2 2026.
  • Optiver Holding sold 336 Treace Medical Concepts shares in Q2 2026, an estimated $924.
  • Treace Medical Concepts made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2579 holding.
  • Optiver Holding first reported a position in Treace Medical Concepts in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Treace Medical Concepts position peaked at $5.49K in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.